Professor of Urology & Pop Health @ NYU & Manhattan VA. Board certified in Urology+ Lifestyle Medicine. Radio host, Mens Health Show @SiriusXM 110. Views my own
🚨 Major shift: @AmericanCancer now directly recommends routine PSA screening for #prostatecancer, moving off pure shared decision-making 🚨
@CACancerJournal
📋 Average risk: PSA every 2 yrs, ages 50-69
📋 High risk (Black men; first-degree relative dx <65 or multiple at any age): annual PSA, ages 45-69
📋 Non-Black w/ one first-degree relative dx ≥65: every 2 yrs, ages 45-69
🔬 Age-adjusted elevated = PSA ≥3.0 (ages 45-69) or ≥6.5 (70-74); repeat in 2 wks to 3 mo, then MRI and/or validated biomarker before biopsy
🛑 70-74 individualized; not recommended ≥75 or if life expectancy <10 yrs
⚠️ Still requires informed consent on benefits, limits, and harms, and departs from USPSTF’s grade C for 55-69
🎯 ACS has moved from “discuss it” to “do it” for average-risk men 50-69 and high-risk men from 45, its biggest change since 2010
🔗 https://t.co/LJRpxycWE8
@UroOnc@urotoday@UrologyTimes@PCF_Science@AmerUrological
Punto y contrapunto en el #CongresoSCHU2026.
@LoebStacy defendió la vigilancia activa y @cjweight , el tratamiento activo en pacientes con cáncer de próstata ISUP 2 de riesgo favorable.
Moderó el Dr. Rodrigo Pinochet.
Congrats to Dr Mary Ellen Taplin on the @PCFnews@PCF_Science Women In Science Lifetime Achievement Award! What an inspirational journey and amazing contributions including most recently the PROTEUS trial #pcfretreat26
How is AI reshaping equity across the research pipeline? Dr. Sarah Amend (@HopkinsMedicine) leads a discussion with Drs. Lakendria Brown, Cornelia Ding, Elisabeth Heath, Stacy Loeb and Louise Kostos.
#ScientificRetreat#PCFRetreat26
New in @JCOOP_ASCO: our @PCF_Science Clinician–Industry Roundtable consensus, “Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.”
Read the paper: https://t.co/3ruP2yOv7l
Cardiovascular disease is a leading noncancer threat in #ProstateCancer, and androgen-deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPIs) can add to existing risk. We propose a practical way for oncology, urology, primary care, and cardiovascular teams to recognize risk early and coordinate prevention while keeping cancer care moving.
Grateful to @PCFnews, @PCF_Science, co-chairs @neerajaiims and @PhillipKooMD, Gina Carithers, and all our clinician and industry collaborators. #CardioOncology
In honor of #ProstateCancer Awareness Month, sharing this episode from the If You Are My Brothers podcast on PSA Screening 2026: New Rules & What Black Men Must Know https://t.co/vSIOgLzoa2 via @YouTube
🎙️Radio time! Join me today on @SIRIUSXM ch 119 @NYUDocs 6-8pET for an exciting lineup: bladder cancer w @marigfern, prostate cancer & mental health @PCFnews segment w @zklaassen_md, sexual medicine w Dr Arthur Burnett, and GLP1s w Dr Jason Sloane
High Decipher scores were associated with a higher odds of immediate treatment over AS in localized prostate ca.
While 🧬genomic testing aligns with actual clinical choices, the real question remains: do these score-guided decisions truly translate into improved long-term survival outcomes? @JNCI_Now@OncoAlert@OpenMedicineHQ@LoebStacy@TylerSbrt
Excellent presentation by @LoebStacy on misinformation to impact - how online information shapes prostate cancer care - representation matters
#COSMO26
At #COSMO26@LoebStacy on how #prostatecancer misinformation is rampant across social media
‼️from myths about causes and unproven "cures" to claims biopsies spread cancer
➡️ ongoing NIH R01 research is studying guideline-discordant content, underrepresented pt perceptions & digital skill interventions
This afternoon, @LoebStacy speaks on the topic "From Misinformation to Impact: How Online Content Shapes Prostate Cancer Care" at #COSMO26.
Revisit her 2024 review article in CA on cancer misinformation in social media: https://t.co/o3oF0JhYd7
@OncoAlert
🎙️Radio time! Join me today on @SIRIUSXM ch 110 @NYUDocs at 6-8pET for an exciting lineup- microplastics & health w Dr Campen, sexual medicine w @drhelenbernie, @PCFnews prostate health segment on survivorship w @CaPsurvivorship and kidney stones w @MSemins